PedAM
Pediatric Disease Annotations & Medicines
| Disease | waldenstrom macroglobulinemia |
| Symptom | C0442874|neuropathy |
| Sentences | 1 |
| PubMedID- 23525653 | We diagnosed the patient with anti-mag/sgpg neuropathy associated with waldenström macroglobulinemia and initiated rituximab monotherapy, i.e., intravenous rituximab at a standard dosage of 375 mg/m2 weekly for 4 weeks. |
Page: 1